The European Commission has granted marketing authorization for Rylaze for use as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients 1 month and older who developed hypersensitivity or silent inactivation to E. coli–derived asparaginase.
DUBLIN, Sept. 21, 2023 /PRNewswire/ Jazz Pharmaceuticals plc today announced that the European Commission has granted marketing authorization for Enrylaze® for use as a component of a.
Jazz Pharmaceuticals (JAZZ) Granted EU Approval for Enrylaze streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Manneken Pis dresses up as a doctor to raise awareness about childhood cancer thebulletin.be - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thebulletin.be Daily Mail and Mail on Sunday newspapers.
Acute lymphoblastic leukaemia is the most common kind of childhood cancer but the drugs containing asparaginase are of poor quality, leaving 70 000 children at risk